Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $361,838 (100.0% shares, 0.0% debt)

Holdings (36)

GLPG GALAPAGOS NV 7.8%
Value ($000) $28,188 Shares 1,025,000 Est. Cost $37.79 Unrealized
ACHC ACADIA HEALTHCARE COMPANY IN 7.6%
Value ($000) $27,438 Shares 692,000 Est. Cost $45.33 Unrealized -0.5%
BBIO BRIDGEBIO PHARMA INC 7.5%
Value ($000) $27,303 Shares 995,000 Est. Cost $30.67 Unrealized -15.7%
MGTX MEIRAGTX HLDGS PLC 7.4%
Value ($000) $26,740 Shares 4,390,837 Est. Cost $7.18 Unrealized -18.4%
ABCL ABCELLERA BIOLOGICS INC 6.0%
Value ($000) $21,536 Shares 7,350,000 Est. Cost $3.80 Unrealized -26.6%
ADCT ADC THERAPEUTICS SA 5.2%
Value ($000) $18,935 Shares 9,515,000 Est. Cost $3.21 Unrealized -18.5%
MIRM MIRUM PHARMACEUTICALS INC 5.2%
Value ($000) $18,654 Shares 451,127 Est. Cost $29.75 Unrealized +40.1%
ICLR ICON PLC 4.9%
Value ($000) $17,825 Shares 85,000 Est. Cost $233.52 Unrealized 0.0%
ROIV ROIVANT SCIENCES LTD 4.9%
Value ($000) $17,745 Shares 1,500,000 Est. Cost $10.80 Unrealized +9.5%
JANX JANUX THERAPEUTICS INC 4.9%
Value ($000) $17,656 Shares 329,768 Est. Cost $47.06 Unrealized +12.4%
SDGR SCHRODINGER INC 3.8%
Value ($000) $13,898 Shares 720,500 Est. Cost $21.79 Unrealized -10.9%
RCKT ROCKET PHARMACEUTICALS INC 3.8%
Value ($000) $13,685 Shares 1,088,706 Est. Cost $15.85 Unrealized -5.0%
ZYME ZYMEWORKS INC 3.3%
Value ($000) $12,005 Shares 820,000 Est. Cost $9.67 Unrealized +44.6%
KURA KURA ONCOLOGY INC 3.2%
Value ($000) $11,541 Shares 1,325,000 Est. Cost $13.30 Unrealized +8.2%
FOLD AMICUS THERAPEUTICS INC 2.4%
Value ($000) $8,666 Shares 920,000 Est. Cost $10.39 Unrealized 0.0%
ZBH ZIMMER BIOMET HOLDINGS INC 2.3%
Value ($000) $8,450 Shares 80,000 Est. Cost $116.71 Unrealized -9.2%
SNDX SYNDAX PHARMACEUTICALS INC 2.3%
Value ($000) $8,196 Shares 620,000 Est. Cost $20.52 Unrealized -16.6%
STTK SHATTUCK LABS INC 2.2%
Value ($000) $8,033 Shares 6,638,935 Est. Cost $5.19 Unrealized -76.2%
IMVT IMMUNOVANT INC 2.1%
Value ($000) $7,568 Shares 305,523 Est. Cost $32.81 Unrealized -13.5%
BLUEPRINT MEDICINES CORP 1.6%
Value ($000) $5,844 Shares 67,000 Est. Cost $90.93 Unrealized
PRTA PROTHENA CORP PLC 1.6%
Value ($000) $5,791 Shares 418,122 Est. Cost $26.88 Unrealized -41.3%
GALAPAGOS NV 1.3%
Value ($000) $4,865 Shares 176,900 Est. Cost Unrealized
CTMX CYTOMX THERAPEUTICS INC 1.1%
Value ($000) $4,022 Shares 3,905,000 Est. Cost $1.23 Unrealized -12.3%
HAE HAEMONETICS CORP MASS 1.0%
Value ($000) $3,646 Shares 46,700 Est. Cost $80.79 Unrealized -0.6%
CNC CENTENE CORP DEL 0.9%
Value ($000) $3,332 Shares 55,000 Est. Cost $62.36 Unrealized 0.0%
SGHT SIGHT SCIENCES INC 0.9%
Value ($000) $3,308 Shares 908,847 Est. Cost $5.83 Unrealized -21.8%
LIVN LIVANOVA PLC 0.9%
Value ($000) $3,242 Shares 70,000 Est. Cost $49.57 Unrealized +3.5%
CRBP CORBUS PHARMACEUTICALS HLDGS 0.9%
Value ($000) $3,186 Shares 270,000 Est. Cost $33.34 Unrealized -49.7%
ERAS ERASCA INC 0.7%
Value ($000) $2,377 Shares 947,110 Est. Cost $2.11 Unrealized +29.7%
SYRE SPYRE THERAPEUTICS INC 0.5%
Value ($000) $1,862 Shares 80,000 Est. Cost $29.32 Unrealized 0.0%
CDNA CAREDX INC 0.5%
Value ($000) $1,713 Shares 80,000 Est. Cost $24.32 Unrealized 0.0%
MURAL ONCOLOGY PUB LTD CO 0.4%
Value ($000) $1,503 Shares 466,822 Est. Cost $5.09 Unrealized
FTRE FORTREA HLDGS INC 0.3%
Value ($000) $1,028 Shares 55,100 Est. Cost $19.49 Unrealized 0.0%
RNTX AILERON THERAPEUTICS INC 0.3%
Value ($000) $931 Shares 404,979 Est. Cost $3.64 Unrealized -16.9%
IMNM IMMUNOME INC 0.2%
Value ($000) $577 Shares 54,342 Est. Cost $14.65 Unrealized -17.5%
OKUR ONKURE THERAPEUTICS INC 0.2%
Value ($000) $548 Shares 63,754 Est. Cost $15.14 Unrealized 0.0%